News

Updates from NHS BSA, MHRA drug safety alerts, and other medical news.

MHRA Alert – Mesalazine and Idiopathic Intracranial Hypertension Risk

Safety Update: Mesalazine and Idiopathic Intracranial Hypertension The MHRA has identified a very rare but important safety signal: idiopathic intracranial hypertension (IIH) has been reported in patients treated with mesalazine. Following review, warnings for IIH are now being added to the product information for all mesalazine products. What You Need to Know IIH is a […]